Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=1383&sort=funder_divisions
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=funder_divisions", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1424&sort=funder_divisions", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1384&sort=funder_divisions", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1382&sort=funder_divisions" }, "data": [ { "type": "Grant", "id": "2613", "attributes": { "award_id": "2037290", "title": "I-Corps: A Mixed Reality Solution for Diagnosis and Recovery of Visual Function Losses due to Age-related, Degenerative Eye Diseases", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 7606, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2020-08-15", "end_date": "2022-01-31", "award_amount": 50000, "principal_investigator": { "id": 7607, "first_name": "Alireza", "last_name": "Tavakkoli", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 903, "ror": "", "name": "Board of Regents, NSHE, obo University of Nevada, Reno", "address": "", "city": "", "state": "NV", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 903, "ror": "", "name": "Board of Regents, NSHE, obo University of Nevada, Reno", "address": "", "city": "", "state": "NV", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is the development and translation of a head mounted display system that provides eye-care professionals and patients with affordable, reliable, and convenient technologies for diagnosing each individual patient’s disease, predicting progression risks, and designing effective vision rehabilitation protocols. A spectrum of conditions including retina ganglion cell (RGC) degeneration, optic disc edema, neovascularization, and retinal hemorrhaging affect the human visual system and are associated with progressive vision threatening diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR), ischemic optic neuropathy (ION), and glaucoma. According to the National Eye Institute (NEI), these eye diseases are expected to affect over 14 million patients in 2020. The main commercial potential of the proposed technology is in eye-care (ophthalmology and optometry) as well as low-vision rehabilitation therapy. In addition, 14 million patients suffering from many forms of vision-threatening retina or optic nerve diseases will benefit from using the proposed technology to improve their functions of daily living. Vision researchers and scientists who study the human visual system will be able to use the product to advance knowledge about the human eye and vision to improve the status of eye care in the U.S.\n\nThis I-Corps project is based on the development of a mixed-reality product that utilizes machine learning and computer vision to model patient's perceptual-functional vision deficit. The deficits are measured in a binocular manner, i.e. for each eye separately. This makes the proposed technology capable of modeling the vision loss for each eye independently. By utilizing these models the proposed device appropriately modifies the visual stimuli to help patients recover lost visual function. The device also may be used by the patient to undertake several functional vision assessments to measure visual fields losses, color and contrast sensitivity, stereo-vision, and acuity, at home. By performing these tests, the proposed device builds baseline measures for each patient and monitors the status and progression of the patient's vision loss over time. The results of these tests may be communicated with the patient's eye care provider to determine suitable interventions when the need arises. The product is based on recent research results integrating the capabilities of taking video captures from two independent cameras and modifying the visual stimuli for each eye independently. These functionalities may make the proposed device an invaluable low-vision aid for patients who have lost mobility and independence due to vision loss.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2688", "attributes": { "award_id": "1912667", "title": "I-Corps: PARROT, a wireless orofacial myofunctional imaging and pressure mapping appliance", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 7901, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-02-01", "end_date": "2022-01-31", "award_amount": 50000, "principal_investigator": { "id": 7904, "first_name": "Heidi", "last_name": "VanRavenhorst-Bell", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 931, "ror": "https://ror.org/00c4e7y75", "name": "Wichita State University", "address": "", "city": "", "state": "KS", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 7902, "first_name": "Jeremy A", "last_name": "Patterson", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, { "id": 7903, "first_name": "Piyush", "last_name": "Kalra", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 931, "ror": "https://ror.org/00c4e7y75", "name": "Wichita State University", "address": "", "city": "", "state": "KS", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is to address a current void in medical and clinical practices across a broad scope of disciplines (e.g., dentofacial orthopedist, speech language pathologist, sleep medicine specialist, respiratory therapist, orofacial myofunctional therapist) specializing in Orofacial Myofunctional Disorders (OMD) (i.e., sleep apnea, dysphagia, malocclusions, tongue thrusts, articulation). Millions of people worldwide are impacted by some intricate and individualized form of OMD each year. Currently, there is a limited number of oral function diagnostic devices available. Providing a device, PARROT, that will capture real-time natural lingual behavior outside a controlled clinical setting may further one?s understanding of the obscure happenings within the oral cavity. Such information may further advance OMD diagnostic and rehabilitation practices as well as promote the engagement of new research across several medical and clinical fields. Recognizing the growing prevalence of OMD across multiple health related disciplines and the projected growth of a multibillion-dollar medical device manufacturing industry, PARROT may address such a need.\n\nThis I-Corps project is purposed toward enhancing one's quality of life by establishing a robust method to view lingual behaviors potentially associated with OMD. The tongue's placement within the oral cavity obstructs and limits accessibility to observe and objectively record natural lingual behaviors (i.e., spatial positioning, placement, movement and performance). Such limitations may dilute biofeedback purposed toward identifying atypical patterns or mechanics potentially causing or promoting an OMD; thereby, impeding the appropriate application to effectively treat the OMD. PARROT is a wireless orofacial myofunctional imaging and pressure mapping appliance that introduces the potential for a systematic approach to objectively evaluate natural lingual behavior (e.g., region specific lingual movement, positional habits, and performance) while allowing an individual to continue routine daily activities and behaviors. To date, a particular proximity sensor has been identified for measuring tongue-palate distance along with contact and motion displacement across the stretch of the tongue in the oral cavity, while a specific pressure mapping matrix will measure intensity of pressure applied by the tongue across the palate and upper dentition. PARROT is currently in an Alpha Prototype state with configuration and optimization of biomaterials continuing prior to Beta Prototype validation.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2695", "attributes": { "award_id": "1910283", "title": "I-Corps: Restoration of Ovarian Endocrine Function in Adolescent Girls with Premature Ovarian Insufficiency", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 7934, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-02-01", "end_date": "2022-01-31", "award_amount": 50000, "principal_investigator": { "id": 7935, "first_name": "Ariella", "last_name": "Shikanov", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 169, "ror": "", "name": "Regents of the University of Michigan - Ann Arbor", "address": "", "city": "", "state": "MI", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 169, "ror": "", "name": "Regents of the University of Michigan - Ann Arbor", "address": "", "city": "", "state": "MI", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is to identify stakeholders and customers and to develop the most appropriate path forward to translate the company's technology to the clinic and bring it to the patients. Currently young girls suffering from premature ovarian insufficiency (POI) as a result of anticancer treatments have limited and inadequate options to undergo puberty and start their transition into adult life. The existing hormone replacement therapy (HRT) applied to induce puberty in girls with POI leads to long-term morbidities, such as decreased bone density, predisposition to obesity and diabetes. The company's technology allows the restoration of ovarian endocrine function in prepubescent girls and has the potential to become a central mainstream treatment for POI, which would result in significant improvement of the short and long-term health and eliminate long-term morbidities associated with premature ovarian failure. The commercial benefit of the proposed treatment would result from significant lower health costs associated with obesity, diabetes and osteoporosis. \n\nThis I-Corps project will further the company's understanding of the current state of the field and the value of the proposed technology, and help identify the next steps for preclinical and clinical studies. The company developed an immunoisolating capsule that supports the survival and function of ovarian allograft eliminating the need for immune suppression. The company's central hypothesis is that ovarian tissue secretes the gonadal hormones, estradiol, progesterone, androstenedione, activins and inhibins, in response to systemic hormone stimulation in a pulsatile and dynamic rate required for physiological progression through puberty, growth and associated metabolic changes. Experimental data from in vivo mouse and primate studies have demonstrated promising results of restoration of hormone function integrated in the endocrine system and neuroendocrine axis, with no evidence of immune rejection or local inflammatory adverse response. The next critical steps in the company's project is to perform customer discovery and identify partners for first-in-human trials.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2709", "attributes": { "award_id": "1926871", "title": "I-Corps: Virtual Clinical Trials Platform", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 7985, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-03-15", "end_date": "2021-05-31", "award_amount": 50000, "principal_investigator": { "id": 7987, "first_name": "Ancha", "last_name": "Baranova", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 239, "ror": "https://ror.org/02jqj7156", "name": "George Mason University", "address": "", "city": "", "state": "VA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 7986, "first_name": "Harsha K", "last_name": "Rajasimha", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 239, "ror": "https://ror.org/02jqj7156", "name": "George Mason University", "address": "", "city": "", "state": "VA", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project would be to enable substantial improvements in clinical trial efficiency. Current industry wide average cost to bring a novel medicine through FDA approval has now exceeded $2.6 Billion. The average time for the same is 10 - 15 years. Typically, industrial customer spends an average of 16,000 to 26,000 US dollars per patient recruited into a phase I, II or III trial, with phase III recruitment costing the highest. With this project's innovative model assisting virtual clinical trials, the cost of recruitment alone can potentially come down significantly as the costs associated with multiple sites setup and monitoring would be eliminated. Each customer will also likely to see significantly reduced dropout during the trials, thereby reducing overall cost and compressing the schedule of the trial.\n\nThis I-Corps project develops a virtual siteless environment for clinical trials. This environment will reduce risks, accelerate trial recruitment using e-consent, aid in conducting multiple virtual follow-up sessions with trial participants without requiring their travel to trial sites. It will also enable collection of data continuously, through participants' wearable devices, web-deployable questionnaires and surveys, home based specimen collection kits or through home visits by a nurse or phlebotomists. This integrated environment for virtual clinical trials will potentially integrate a patient facing application for text, image, video and voice interactions, data hub for integration of clinical, molecular, and digital biomarkers as well as capture of health information.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2738", "attributes": { "award_id": "1917312", "title": "I-Corps: Time-Dependent Protein Response Platform", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [], "start_date": "2019-04-01", "end_date": "2020-03-31", "award_amount": 50000, "principal_investigator": { "id": 8090, "first_name": "Rhonda", "last_name": "Shrader", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 176, "ror": "", "name": "University of California-Berkeley", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 176, "ror": "", "name": "University of California-Berkeley", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is the development of novel therapeutics for the treatment of respiratory disease. For example, a significant percentage of pre-term babies are unable to produce lung surfactant. This biological material, which contains lipid and specialized proteins, significantly increases the ability of the lung to expand and contract. It also enhances the transfer of oxygen to blood. Insufficient levels of lung surfactant results in neonatal respiratory distress syndrome (NRDS), a condition that is fatal in a significant number of cases. The current standard of care is a purified extract obtained from pig lung. The purification process used to obtain this product is demanding, resulting in a final product that varies significantly in protein and lipid content. For this reason, there is significant interest in the development of novel synthetic lung surfactants. However, chemically-designed lung surfactants that have been developed to date are no longer used because of low biological potency. In addition to its therapeutic utility, a potent, concentrated lung surfactant may also be useful in treating babies with less severe forms of this disease and may be useful in the treatment of adult diseases such as adult respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disorder (COPD). \n\nThis I-Corps project is to commercialize a scalable, fully active synthetic lung surfactant for use in the treatment of neonatal and adult respiratory disorders. The approach is unique since computational models of lung surfactants are being used to identify key structural features that are required for biological activity and manufacturability. The project's hypothesis is that this synthetic lung surfactant can be successfully commercialized at reasonable cost. In addition, we hypothesize that the knowledge gained can be leveraged to develop other biotherapeutics requring interaction between bioactive proteins and lipid. We will use the lean startup method to perform customer interviews that assess the commercial viability of a novel synthetic lung surfactant.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2740", "attributes": { "award_id": "1917343", "title": "I-Corps: Non-Contact Remote Breathing Analysis through Visualization of Thermal and CO2 Flow", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 8097, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-04-01", "end_date": "2021-09-30", "award_amount": 50000, "principal_investigator": { "id": 8098, "first_name": "Min-Hyung", "last_name": "Choi", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 773, "ror": "", "name": "University of Colorado at Denver-Downtown Campus", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 773, "ror": "", "name": "University of Colorado at Denver-Downtown Campus", "address": "", "city": "", "state": "CO", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is in providing new medical diagnostic devices, software, and services for broad respiratory and pulmonary disease groups. Respiration monitoring is an important physiological measurement taken to determine the health of an individual. Due to the advantages of this project's remote sensing, the technology is expected to have a potential for commercial success for both in-clinic care and a home-based long term monitoring, contributing toward improved health outcomes. \n\nThis I-Corps project is based on recent innovations in remote sensing for breathing activities. Conventional respiratory monitoring systems in a clinical setting require patients to wear devices, such as elastic bands around the chest or use invasive masks or tubes connected to the face, which cause patient discomfort and are ill-suited for long-term monitoring. Existing remote sensing techniques are not accurate enough due to the indirect nature of inferring breathing behaviors through chest movements or utilizing correlation functions. This project's system aims for both patient comfort and accurate and comprehensive analysis of patient breathing behaviors. It employs a specifically designed IR imaging camera and a novel software system to directly capture and visualize the human exhale carbon dioxide (CO2) activities in front of the face. This remote sensing helps promote patient comfort for a long-term measurement and it extracts clinically valuable information in a non-invasive way. Since it measures the breathing activities directly from the turbulent exhale behavior, it is accurate and comprehensive enough to obtain breathing rate, speed, strength, tidal volume, and nose/mouth distribution which could be crucial for the diagnosis of obstructive breathing, sleep apnea, and various pulmonary diseases.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2819", "attributes": { "award_id": "1938166", "title": "I-Corps: Virtual Reality Biofeedback Education Technologies", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 8396, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-07-01", "end_date": "2020-12-31", "award_amount": 50000, "principal_investigator": { "id": 8397, "first_name": "John", "last_name": "Sipple", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 279, "ror": "https://ror.org/05bnh6r87", "name": "Cornell University", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 279, "ror": "https://ror.org/05bnh6r87", "name": "Cornell University", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is to provide a new means for how educational content is delivered in virtual reality (VR) with consistent impact, independent of demographics and environment. This technology offers a higher level of personalized learning that can be administered without requiring accompanying professional development for teachers due to the delivery of lessons in a highly controlled virtual environment. Removing this dependence on additional training facilitates the adoption across schools with limited resources. The increased efficacy in learning and retention of material through VR has made it a technology of interest for teachers and school administrators. This technology can be used across a range of educational subjects, and with the immersive personalized learning experience, offers a high-quality learning solution for educators.\n\nThis I-Corps project uses biofeedback to personalize learning in virtual reality (VR). The technology manipulates a user's environment based on their physiological reactions. This can include the surrounding physical objects, light source, or landscape. The auditory manipulation is a more indirect change where the audio path of a lesson is based on the emotional reaction of a user, such as when someone is distracted or agitated. This emotional reaction is based on tracking numerous physiological inputs over time. The identification process is based on existing research using the same physiological measures to classify users' emotional states and improved through this project This level of adaptation enables a higher degree of VR program customization and more a meaningful learning experience while using the technology.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2830", "attributes": { "award_id": "1932343", "title": "I-Corps: Decision Support Tool to Assess Distributed Electricity Needs", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 8449, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-06-15", "end_date": "2021-05-31", "award_amount": 50000, "principal_investigator": { "id": 8450, "first_name": "Lisa", "last_name": "Bosman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 252, "ror": "", "name": "Purdue University", "address": "", "city": "", "state": "IN", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 252, "ror": "", "name": "Purdue University", "address": "", "city": "", "state": "IN", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project will have a direct impact on the energy industry, and indirect effects to all people connected to the energy grid. Energy generation, sources and distribution methods have been continuously evolving over the past decade. In 2018, solar-produced energy accounted for 1.6% of the electricity generated in the U.S., up from 0.11% in 2012. By 2020, solar-produced energy is forecasted to account for 5% of U.S. generated electricity. With the increased efficiency associated with solar energy production and distribution, local homeowners have also assumed the role of energy generators, even getting credit for access electricity supplied to the grid given the policy around net-metering. When planning their energy distribution frameworks, utility companies have to take these changes in energy consumption and generation into account when planning their energy distribution frameworks. Devising methods and tools which can accurately estimate near-future (5-10 days) local weather forecasts and its implications for changes in solar energy production will positively impact utility companies, reducing stakeholder costs currently associated with forecasting errors.\n\nThis I-Corps project aims to conduct customer discovery and validation for a decision support tool which incorporates localized real-time weather data and near-future forecasted weather data to predict site-specific weather parameters for the purpose of estimating solar energy generation at the region level. This tool assists utility companies (who own solar arrays and/or have customers who own solar arrays) to level-out load demand and supply. In addition, this tool assists solar energy system owners to verify the system is working properly. This I-Corps project is an extension of prior research to develop a framework to model long-term efficiency and reliability of photovoltaic (PV) systems, and then verify accuracy through comparison to real-time PV system performance data. From a practical perspective, this produced a model to estimate performance and value of used solar energy systems. This I-Corps project leverages the previously developed framework but incorporates multiple weather data sets (e.g., real-time weather data, historical weather data, and near-future forecasted weather data) to estimate near-future (5-7 days) performance. It is proposed that this focus on big data will be beneficial to utility companies to level out demand and supply.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2834", "attributes": { "award_id": "1934296", "title": "I-Corps: Minimally-Invasive Gastrointestinal Nutrient Delivery Device", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 8467, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-06-15", "end_date": "2021-11-30", "award_amount": 50000, "principal_investigator": { "id": 8468, "first_name": "Elizabeth", "last_name": "Demetriades", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 152, "ror": "https://ror.org/03taz7m60", "name": "University of Southern California", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 152, "ror": "https://ror.org/03taz7m60", "name": "University of Southern California", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is to provide a new approach to managing excess weight, one of the major health crises of our time. Obesity now affects nearly 40% of the US population. It is the main contributor to chronic disease, including type 2 diabetes and coronary artery disease. Current weight loss medications and devices are expensive and only moderately effective, with significant concern for adverse events. One of the most effective therapies, bariatric surgery, is available to or acceptable to less than 1% of the medically eligible US population. This project develeops a medical device that can be placed and removed as needed in an outpatient setting without the need for advanced technical skills or equipment. The initial commercialization efforts will be with pre-operative patients who are being denied surgery due to excess weight and, after demonstration of clinical benefit in this group, expand to other customer segments. The device has the potential to be widely used for weight loss by individuals with limited therapeutic weight loss options.\n\nThis I-Corps project is aimed at developing a minimally-invasive, fully-reversible medical device that delivers nutrient to the upper intestine in a manner that simulates nutrient delivery following the highly effective weight-loss surgery, gastric bypass. No surgery or drugs are used, rather the underlying strategy is to use nutrient in a novel manner to control appetite. Following gastric bypass surgery, nutrient floods the upper intestine after eating and this signals to the body that it has been overfed, despite significant caloric restriction. This response is distinct from the fasting response induced by simple dieting. The device uses a modified slim enteral feeding tube to direct a select nutrient formulation to the desired site in the small intestine. This project is based on clinical research that demonstrates that appetite can be rapidly suppressed, and food intake reduced by a single dose of nutrient delivered rapidly to the upper intestine by an enteral feeding tube. A prototype device has been developed and tested in a pilot clinical study.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "2835", "attributes": { "award_id": "1935233", "title": "I-Corps: Sterile Connection Interface Technology", "funder": { "id": 3, "ror": "https://ror.org/021nxhr62", "name": "National Science Foundation", "approved": true }, "funder_divisions": [ "Technology, Innovation and Partnerships (TIP)", "I-Corps" ], "program_reference_codes": [], "program_officials": [ { "id": 8471, "first_name": "Ruth", "last_name": "Shuman", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2019-06-15", "end_date": "2021-12-31", "award_amount": 50000, "principal_investigator": { "id": 8473, "first_name": "Sarah", "last_name": "Elfering", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 227, "ror": "", "name": "University of Minnesota-Twin Cities", "address": "", "city": "", "state": "MN", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 8472, "first_name": "Ibrahim O", "last_name": "Yekinni", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 227, "ror": "", "name": "University of Minnesota-Twin Cities", "address": "", "city": "", "state": "MN", "zip": "", "country": "United States", "approved": true }, "abstract": "The broader impact/commercial potential of this I-Corps project is the improvement of sterility in industrial scenarios where fluids are transferred between tubing. Possible application areas include food and beverage manufacturing, pharmaceutical manufacturing, and healthcare settings involving procedures like peritoneal dialysis, colostomy, or central catheterization. Specifically with peritoneal dialysis for end stage renal disease, this technology will help to reduce the risk of peritonitis which is a major barrier to the more widespread adoption of this dialysis modality. The American healthcare system could save between $7 - $10 billion annually if all end stage renal disease patients utilized this dialysis method. Beyond dialysis in end stage renal disease, the device will also reduce the amount of antibiotics given for empirical infection treatment and will help in the fight towards prevention of antibiotic resistance.\n\nThis I-Corps project further develops a connection interface technology that allows sterile connection of tubing, requiring limited handling. By utilizing magnetic attractive forces, capped tubes can be uncapped, connected, disconnected and recapped away from possible contamination through touch, respiratory droplets or environmental contaminants. While most connection interfaces for sterile fluid transfer focus on modifying the tubing being connected to prevent contamination, this technology focuses on the environment where connection occurs instead. It provides a sterile environment through the enclosure and maintains sterility with physical barriers and by replacing the need for human manipulation with magnetically controlled movements. This limits handling and subsequently reduces the likelihood of contamination.\n\nThis award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.", "keywords": [], "approved": true } } ], "meta": { "pagination": { "page": 1383, "pages": 1424, "count": 14236 } } }